Nightstar Therapeutics plc (NITE) EPS Estimated At $-0.34; Profile of 0 Analysts Covering Alkermes plc (ALKS) Standard RecorderAnalysts expect Nightstar Therapeutics plc (NASDAQ:NITE) to report $-0.34 EPS on April, 2.After having $-0.27 EPS previously, Nightstar Therapeutics plc's ...